Future-proof your Central Sterile Services Department (CSSD)

In response to the increasing demand to process surgical instruments within developing CSSDs, the upgradable STERRAD™ Systems are designed to adapt to new procedures and materials, to maximise surgical outcomes without the purchase of new technology.

An increasing proportion of healthcare procedures originate from outpatient, ambulatory care.1 Reprocessing of surgical instruments is a central component of every surgical centre. CSSD Technicians are therefore an essential part of patient care during surgery, owing to their responsibility to clean, decontaminate, process, sterilize and manage the required medical instruments and equipment. However, their dedication and diligence may be challenged when facilities aren’t sufficiently equipped with the appropriate hardware and tools to support a scalable workload.

Developing methods to reduce the stress of preventable future events is important.

Is your business or team developing by adding procedures and investing in robotics, or are you aiming to increase efficiency? Get a consultation from an ASP expert today on how our technology can future-proof your CSSD.

ASP Recommendations

As evidence suggests several points of potential failure in endoscope reprocessing, ASP’s recommendations are simple:

1

What Can be sterilized should be sterilized

2

What cannot be sterilized should be reprocessed in an advanced Automatic Endoscope Reprocessor

These recommendations align with that of the U.S. Food and Drug Administration (FDA). The FDA guidance document Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling. Guidance for Industry and Food and Drug Administration Staff states that “Users should be instructed to thoroughly clean [semi-critical devices] and then reprocess them by sterilization. If the device design does not permit sterilization (e.g., device materials cannot withstand sterilization), then high level disinfection should be used.”2

ASP Products work together to work for you

STERRAD™ Systems deliver sterility assurance via an upgradeable platform. As medical device designs and guidelines evolve over time, this system can adapt to the increasing demands of reprocessing to subsequently maximise clinical, economic and operational outcomes.

  • STERRAD™ Systems are the only upgradable platform to develop new cycles which are available for purchase as a software upgrade on your existing machine. Purchase of updated machines is not required.

  • The STERRAD NX™ System with ALLClear™ Technology is one of the latest products forming part of the STERRAD™ Systems platform; it is the result of over 25 years of innovation in hydrogen peroxide gas plasma sterilization technology

  • The STERRAD™ 100NX System with ALLClear™ Technology includes a 24-minute EXPRESS Cycle, which is compatible with da Vinci® endoscopes, rigid and semi-rigid endoscopes without lumens and rechargeable batteries.

  • Increased compliance with ALLClear™ Technology minimises cycle cancellations; ASP ACCESS™ Technology and instrument tracking system (ITS) provide audit-ready data alongside intuitive on-screen guides.

  • STERRAD™ Systems:

    • Have increasing support, with over 20,000 full medical device manufacturer endorsements to date and growing

    • Have integrated quality systems to enhance compliance to guidelines and hospital policies; the systems can be integrated with ASP ACCESS™ Technology to automatically document the sterilisation process

    • Are capable of sterilizing a wide range of materials, supporting the development of your CSSD as you utilise new procedures

    • Reduce consumable waste and cancelled cycles via ALLClear™ Technology

Please find the following examples of updates that did not require purchase of a new system, which helped ASP customers stay up-to-date:

Web_STERRAD-NX
2005

STERRAD NX™ System launched with 2 cycles: Standard & Advanced

Web_100NX-Legacy
2007

STERRAD™ 100NX System launched with 2 cycles: Standard & Flex

2011

STERRAD™ 100NX System EXPRESS Cycle; compatible with the Intuitive Surgical® da Vinci® Surgical Endoscope

2012

STERRAD™ 100NX System DUO Cycle; validated for flexible scopes & cameras

NX100-AND-NX-toghther
2016

STERRAD NX™ System with ALLClear™ Technology

STERRAD™ 100NX System with ALLClear™ Technology


Software upgrade to reduce cycle cancellations, connect to ASP ACCESS™ Technology and ITS, and provide on-screen guides to increase compliance

2005

STERRAD NX™ System launched with 2 cycles: Standard & Advanced

 
2007

STERRAD™ 100NX System launched with 2 cycles: Standard & Flex

2011

STERRAD™ 100NX System EXPRESS Cycle; compatible with the Intuitive Surgical® da Vinci® Surgical Endoscope

 
2012

STERRAD™ 100NX System DUO Cycle; validated for flexible scopes & cameras

2016

STERRAD NX™ System with ALLClear™ Technology

STERRAD™ 100NX System with ALLClear™ Technology


Software upgrade to reduce cycle cancellations, connect to ASP ACCESS™ Technology and ITS, and provide on-screen guides to increase compliance

References

  1. Kumar, P., & Parthasarathy, R. (2021, July 1). Walking out of the hospital: The continued rise of ambulatory care and how to take advantage of it. McKinsey & Company. https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/walking-out-of-the-hospital-the-continued-rise-of-ambulatory-care-and-how-to-take-advantage-of-it

  2. U.S. Food and Drug Administration, (2015, March 17). Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling. Guidance for Industry and Food and Drug Administration Staff.

*ASP AEROFLEX™ AER™ has been cleared by the United States FDA for high-level disinfection of flexible, semi-critical endoscopes at a high level.

The third-party trademarks used herein are the properties of their respective owners.

AD-230026-01-CT_A-MDR

Disclaimer

The content of this website is aimed exclusively at healthcare professionals (HCPs) and not at the general public. Please confirm by clicking below that you are a healthcare professional, duly authorized to practice in your field. ASP EMEA declines all responsibility in case of unauthorized consultation.